BioMarin Pharmaceutical
BMRN
#1885
Rank
โ‚ฌ9.16 B
Marketcap
47,70ย โ‚ฌ
Share price
-0.79%
Change (1 day)
-22.86%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): โ‚ฌ0.61 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are โ‚ฌ3.09 Billion. In 2024 the company made an earning of โ‚ฌ0.45 Billion, an increase over its 2023 earnings that were of โ‚ฌ0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.61 B34.21%
2024 โ‚ฌ0.45 B187.31%
2023 โ‚ฌ0.15 B26.07%
2022 โ‚ฌ0.12 B-298.51%
2021 -โ‚ฌ63.57 Million78.04%
2020 -โ‚ฌ35.71 Million-55.36%
2019 -โ‚ฌ79.99 Million-33.56%
2018 -โ‚ฌ0.13 Billion297.78%
2017 -โ‚ฌ30.27 Million-95.68%
2016 -โ‚ฌ0.71 Billion437.12%
2015 -โ‚ฌ0.14 Billion23.91%
2014 -โ‚ฌ0.11 Billion-29.25%
2013 -โ‚ฌ0.15 Billion49.23%
2012 -โ‚ฌ99.78 Million171.11%
2011 -โ‚ฌ36.81 Million103.01%
2010 -โ‚ฌ18.13 Million-3903.54%
2009 โ‚ฌ0.47 M-98.31%
2008 โ‚ฌ28.19 M-189.7%
2007 -โ‚ฌ31.44 Million51.02%
2006 -โ‚ฌ20.82 Million-61.58%
2005 -โ‚ฌ54.18 Million-56.59%
2004 -โ‚ฌ0.13 Billion95.13%
2003 -โ‚ฌ63.95 Million12.09%
2002 -โ‚ฌ57.05 Million73.19%
2001 -โ‚ฌ32.95 Million18.32%
2000 -โ‚ฌ27.84 Million19.65%
1999 -โ‚ฌ23.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚ฌ7.67 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.44 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚ฌ91.98 Million-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚ฌ23.15 Million-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ4.2 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.24 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA